Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Roots

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|June 18, 2005
Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function testsJürgen Brockmöller, Torben Thomsen, Marcus Wittstock, et al.
European Journal of Biochemistry|April 16, 2002
Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membranePyotr Kisselev, Dieter Schwarz, Karl-Ludwig Platt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 15, 2003
Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patientsIngrid Mai, Elke Störmer, Steffen Bauer, et al.
Journal of Perinatal Medicine|July 5, 2008
Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasiaGabriele Kewitz, Stefan Wudel, Hartmut Hopp, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadolJulia Kirchheiner, Jan-Tobias H A Keulen, Steffen Bauer, et al.
Biomedical Chromatography : BMC|March 29, 2002
Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detectionSteffen Bauer, Elke Störmer, Rolf Kaiser, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokineticsJulia Kirchheiner, Gunnar Müller, Ingolf Meineke, et al.
Pharmacogenetics|April 30, 2004
Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonistsRolf Kaiser, Pierre-Benoit Tremblay, Orhan Sezer, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteersJulia Kirchheiner, Jürgen Brockmöller, Ingolf Meineke, et al.
European Journal of Clinical Pharmacology|September 21, 2007
Vitamin D receptor haplotypes protect against development of colorectal cancerJana Flügge, Solveigh Krusekopf, Mark Goldammer, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|June 18, 2005
Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function testsJürgen Brockmöller, Torben Thomsen, Marcus Wittstock, et al.
European Journal of Biochemistry|April 16, 2002
Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membranePyotr Kisselev, Dieter Schwarz, Karl-Ludwig Platt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 15, 2003
Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patientsIngrid Mai, Elke Störmer, Steffen Bauer, et al.
Journal of Perinatal Medicine|July 5, 2008
Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasiaGabriele Kewitz, Stefan Wudel, Hartmut Hopp, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadolJulia Kirchheiner, Jan-Tobias H A Keulen, Steffen Bauer, et al.
Biomedical Chromatography : BMC|March 29, 2002
Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detectionSteffen Bauer, Elke Störmer, Rolf Kaiser, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokineticsJulia Kirchheiner, Gunnar Müller, Ingolf Meineke, et al.
Pharmacogenetics|April 30, 2004
Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonistsRolf Kaiser, Pierre-Benoit Tremblay, Orhan Sezer, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteersJulia Kirchheiner, Jürgen Brockmöller, Ingolf Meineke, et al.
European Journal of Clinical Pharmacology|September 21, 2007
Vitamin D receptor haplotypes protect against development of colorectal cancerJana Flügge, Solveigh Krusekopf, Mark Goldammer, et al.
Pageof 10